The Oct. 14 subpoena was related to the sales, marketing and reimbursement support practices of Medtronic’s neurostimulation devices. Medtronic has said that it will cooperate with the investigation.
Read the Wall Street Journal report on Medtronic’s subpoena.
Read other coverage on Medtronic:
– Medtronic Receives First FDA Clearance in Pediatric AIS Category for CD Horizon Spinal System
– Medtronic Receives FDA 510(k) Clearance for Spinal Cord Stimulator Trialing Cable
– Medtronic Partners With Ziehm Imaging in 3D Intraoperative Technology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
